Neochem Bio IPO Subscription Status
Neochem Bio IPO received bids for 4,76,06,400 shares against 30,52,800 offered, an overall subscription of 15.59x at the close of bidding (4 Dec 2025). QIBs lead at 21.97x.
Last updated · day 3 figures
- Retail
- 9.42x
- NII
- 21.50x
- QIB
- 21.97x
- Total
- 15.59x
Where the demand is
Neochem Bio IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 8,71,200 | 1,91,42,400 | ₹187.60 Cr | 21.97x |
| NII | 6,55,200 | 1,40,88,000 | ₹138.06 Cr | 21.50x |
| bNII above ₹10 lakh | 4,36,800 | 1,14,93,600 | ₹112.64 Cr | 26.31x |
| sNII ₹2–10 lakh | 2,18,400 | 25,94,400 | ₹25.43 Cr | 11.88x |
| Retail | 15,26,400 | 1,43,76,000 | ₹140.88 Cr | 9.42x |
| Total | 30,52,800 | 4,76,06,400 | ₹466.54 Cr | 15.59x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Application-wise breakup and allotment chances
| Category | Lots reserved | Applications | Applied | Chance per application |
|---|---|---|---|---|
| QIB | — | 27 | — | — |
| NII | — | 1,629 | — | — |
| bNII | — | 964 | — | — |
| sNII | — | 665 | — | — |
| Retail | — | 5,990 | — | — |
"All valid" means applications are fewer than the lots reserved, so every valid application should get at least one lot. When applications exceed lots, allottees are picked by computerised lottery and "1 in X" is the rough chance for one application. The real chance is usually a little better: bids below the cut-off price and invalid applications are removed before the lottery.
Neochem Bio IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 21.97x |
| NII | 21.50x |
| bNII | 26.31x |
| sNII | 11.88x |
| Retail | 9.42x |
| Total | 15.59x |
| Total added | 15.59x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Neochem Bio IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Qualified Institutional Buyers | 8,71,200 | 28.54% |
| Non-Institutional Investors | 6,55,200 | 21.46% |
| bNII · above ₹10 lakh | 4,36,800 | 67% of NII |
| sNII · ₹2–10 lakh | 2,18,400 | 33% of NII |
| Retail Individual Investors | 15,26,400 | 50.00% |
| Public issue | 30,52,800 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Neochem Bio IPO subscription: FAQs
- What is the overall subscription of Neochem Bio IPO?
- Neochem Bio IPO is subscribed 15.59x overall as of day 3 (4 December 2025), with bids for 4,76,06,400 shares against 30,52,800 offered.
- What is the retail subscription of Neochem Bio IPO?
- The retail portion is subscribed 9.42x as of day 3 (4 December 2025).
- What is the QIB and NII subscription of Neochem Bio IPO?
- QIBs have subscribed 21.97x of their portion, and NIIs 21.50x (bNII 26.31x, sNII 11.88x) as of day 3 (4 December 2025).
- How can I check Neochem Bio IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Neochem Bio IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 4 December 2025.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.